Deruxtecan is an ADC drug-linker conjugate composed of an DX-8951 derivative (DXd) and amaleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.In VitroAntibody-drug conjugates deliver anticancer agents selectively and efficiently to tumor tissue and have significant antitumor efficacy with a wide therapeutic window. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:Camptothecins.
Specifications and Purity: ≥99%
Molecular Formula: C52H56FN9O13
Molecular Weight: 1034.05
PubChem CID: 118305111
Isomeric SMILES: CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C5[C@H](CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)NC(=O)COCNC(=O)CNC(=O)[C@H](CC7=CC=CC=C7)NC(=O)CNC(=O)CNC(=O)CCCCCN8C(=O)C=CC8=O)O
- UPC:
- 51241219
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- D646872-10mg
- CAS:
- 1599440-13-7
- Product Size:
- 10mg
akash.verma@cenmed.com
(732) 447-1115





